WeVote

Bill

Bill

SM 21

STUDY OVERDOSE PREVENTION CENTERS

2026 Regular Session Introduced by Heather Berghmans and 1 co-sponsor

New Mexico will study supervised overdose prevention centers to assess their feasibility, legal status, and potential public health benefits for addressing opioid deaths.

Signed
0
WeVote Research Nonpartisan
Bill Summary · SM 21

Legislative bill overview

SM 21 directs New Mexico to conduct a comprehensive study of overdose prevention centers (also known as supervised consumption sites), which are facilities where people can use pre-obtained drugs under medical supervision. The bill requires examining operational models, legal frameworks, public health outcomes, and implementation feasibility for potential future centers in New Mexico.

Why is this important

Overdose deaths remain a critical public health crisis, and supervised consumption sites have shown evidence in other jurisdictions of reducing fatal overdoses, disease transmission, and emergency room visits while connecting users to treatment services. This study positions New Mexico to make evidence-based policy decisions about whether such facilities could address its opioid crisis, though it commits no funds or locations at this stage.

Potential points of contention

  • Public safety concerns: Opponents worry that such facilities normalize drug use, may attract criminal activity, or create neighborhood opposition—though evidence from established sites in other cities offers mixed support for these concerns
  • Legal ambiguity: Federal law technically prohibits operating such sites, creating uncertainty about whether New Mexico could legally establish them even after positive study findings
  • Resource allocation debate: Critics may argue the state should prioritize funding treatment and prevention rather than studying harm reduction infrastructure that may face federal legal barriers

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.